Literature DB >> 17380485

High-performance liquid chromatographic enantioseparation of 1-(aminoalkyl)-2-naphthol analogs on polysaccharide-based chiral stationary phases.

Anita Sztojkov-Ivanov1, Diana Tóth, István Szatmári, Ferenc Fülöp, Antal Péter.   

Abstract

The enantiomers of various 1-(alpha-aminobenzyl)-2-naphthol and 1-(aminoalkyl)-2-naphthol analogs were separated on cellulose-tris-3,5-dimethylphenyl carbamate-based chiral stationary phases (Chiralcel OD-H and Chiralcel OD-RH), using n-hexane/2-propanol/diethylamine or phosphate buffer/organic modifier mobile phases. The 3,5-dimethylphenyl carbamoylated cellulose columns were effective in both normal and rev ersed-phase modes. The effects of the mobile phase composition, the pH, the buffer concentration, and the structures of the substituents on the 2-naphthol on the enantioseparations were studied. The absolute configuration and elution sequence were determined for 1-(1-amino-2-methylpropyl)-2-naphthol: the elution sequence was S < R.

Entities:  

Year:  2007        PMID: 17380485     DOI: 10.1002/chir.20392

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  2 in total

1.  High-performance liquid chromatographic enantioseparation of Betti base analogs on a newly developed isopropyl carbamate-cyclofructan6-based chiral stationary phase.

Authors:  Anita Aranyi; István Ilisz; Zoltán Pataj; István Szatmári; Ferenc Fülöp; Daniel W Armstrong; Antal Péter
Journal:  Chirality       Date:  2011-06-16       Impact factor: 2.437

2.  Separation of Betti Reaction Product Enantiomers: Absolute Configuration and Inhibition of Botulinum Neurotoxin A.

Authors:  John H Cardellina; Rebecca C Vieira; Vanessa Eccard; Janet Skerry; Vicki Montgomery; Yvette Campbell; Virginia Roxas-Duncan; William Leister; Christopher A Leclair; David J Maloney; Daniele Padula; Gennaro Pescitelli; Ilja Khavrutskii; Xin Hu; Anders Wallqvist; Leonard A Smith
Journal:  ACS Med Chem Lett       Date:  2011-03-10       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.